 |
|
|
|
|
|
|
|
|
|
|
|
1 to 8 of 8 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Solomon B. on NEWS: First Crystal Structure of Monoclonal Antibody Binding to Aβ, The paper of Gardberg et al. (1) describes, in an elegant and convincing way, the molecular... 3 Oct 2007.
|
|
|
 |
|
|
Solomon B. on NEWS: Immunotherapy Update: Toward Patches and Creams, The skin is a well-established effective route for vaccination. The authors
evaluate the... 26 Jan 2007.
|
|
|
|
|
|
Solomon B. on PAPER: Zurbriggen R. et al., 2005, This paper reports a novel active immunization method against Aβ peptide by displaying the... 10 Oct 2005.
|
|
|
|
|
|
Solomon B. on NEWS: Primate Model Promising for Studying Aβ Vaccine, This paper deals with immunization of healthy old monkeys with fibrillar Aβ42. These animals... 17 Mar 2004.
|
|
|
|
|
|
Solomon B. on NEWS: Antiinflammatory Drugs Protect Hippocampal Neurogenesis, These two recent exciting studies demonstrate that local inflammation inhibits adult... 19 Jan 2004.
|
|
|
|
|
|
Solomon B. on NEWS: Alzheimer’s Vaccine: In Some Patients, at Least, It Might Just Work, One of the critical questions in β-amyloid immunotherapy is whether depletion of the amyloid... 27 May 2003.
|
|
|
|
|
|
Solomon B. on NEWS: Plaque Clearance, Antibody Isotype Are Key for Passive Aβ Immunization, The immunological concept in the treatment of conformational diseases, such as Alzheimer’s, is... 13 Feb 2003.
|
|
|
|
|
|
Solomon B. on NEWS: The Alzheimer's Vaccination Story, Continued, The McLaurin et al. paper confirmed our findings that the key sequence for dissolving as well as... 18 Nov 2002.
|
|
|
|
|
|
|
1 to 8 of 8 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our most recent Webinar: 
